Cargando…

Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis

PURPOSE: Symptoms of psychotic disorders can complicate efforts to accurately evaluate patients’ medication ingestion. The digital medicine system (DMS), composed of antipsychotic medication co-encapsulated with an ingestible sensor, wearable sensor patches, and a smartphone application, was develop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fowler, J Corey, Cope, Nathan, Knights, Jonathan, Fang, Hui, Skubiak, Taisa, Shergill, Sukhi S, Phiri, Peter, Rathod, Shanaya, Peters-Strickland, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886232/ https://www.ncbi.nlm.nih.gov/pubmed/33603385 http://dx.doi.org/10.2147/NDT.S290793

Ejemplares similares

Hummingbird Study: a study protocol for a multicentre exploratory trial to assess the acceptance and performance of a digital medicine system in adults with schizophrenia, schizoaffective disorder or first-episode psychosis
por: Fowler, J Corey, et al.
Publicado: (2019)

T96. RESULTS OF THE HUMMINGBIRD STUDY A MULTICENTRE, PRAGMATIC TRIAL OF A DIGITAL MEDICINE SYSTEM
por: Fowler, Justin, et al.
Publicado: (2020)

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
por: Whicher, Clare Alexandra, et al.
Publicado: (2019)

Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial
por: Holt, Richard I. G., et al.
Publicado: (2019)

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
por: Green, Alastair, et al.
Publicado: (2019)

Lifestyle Interventions in Preventing Excess Weight Gain in First Episode of Psychosis (FEP): A Systematic Review
por: Adeoye, Margret, et al.
Publicado: (2023)

Reducing weight gain in people with schizophrenia, schizoaffective disorder, and first episode psychosis: describing the process of developing the STructured lifestyle Education for People With SchizophrEnia (STEPWISE) intervention
por: Carey, Marian E., et al.
Publicado: (2018)

Results of a prospective, mixed methods study to assess feasibility, acceptability and effectiveness of TRIumPH (Treatment and Recovery In PsycHosis): an integrated care pathway for psychosis, compared to usual treatment
por: Rathod, Shanaya, et al.
Publicado: (2020)

Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis.
por: Cegalis, J. A., et al.
Publicado: (1985)

Protocol for a multicentre study to assess feasibility, acceptability, effectiveness and direct costs of TRIumPH (Treatment and Recovery In PsycHosis): integrated care pathway for psychosis
por: Rathod, Shanaya, et al.
Publicado: (2016)

A symptom-based approach to treatment of psychosis in autism spectrum disorder
por: Bell, Victoria, et al.
Publicado: (2018)

Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis
por: Fryar-Williams, Stephanie, et al.
Publicado: (2015)

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
por: Foster, Jessica, et al.
Publicado: (2017)

A symptom-based approach to treatment of psychosis in autism spectrum disorder in October 2017–ERRATUM
por: Bell, Victoria, et al.
Publicado: (2018)

Social isolation and psychosis: an investigation of social interactions and paranoia in daily life
por: Fett, Anne-Kathrin J., et al.
Publicado: (2021)

The neural mechanisms of social reward in early psychosis
por: Fett, Anne-Kathrin J, et al.
Publicado: (2019)

The Hummingbird and the Hawk/
por: Padden, R,C

Molecular Mechanism Biomarkers Predict Diagnosis in Schizophrenia and Schizoaffective Psychosis, with Implications for Treatment
por: Fryar-Williams, Stephanie, et al.
Publicado: (2023)

Molecular Mechanisms Provide a Landscape for Biomarker Selection for Schizophrenia and Schizoaffective Psychosis
por: Fryar-Williams, Stephanie, et al.
Publicado: (2023)

4327 Structural Neural Correlates of Social Functioning in First Episode Psychosis and Malleability in Response to Targeted Cognitive Training
por: Miley, Kathleen, et al.
Publicado: (2020)

TMS-EEG in the Investigation of Excitation-Inhibition Imbalance in Psychosis and Cognition
por: Michalopoulou, Panayiota G, et al.
Publicado: (2023)

COVID-19 and Black, Asian, and Minority Ethnic Communities: A Complex Relationship Without Just Cause
por: Phiri, Peter, et al.
Publicado: (2021)

Exploring psychotic symptoms: a comparison of motor related neuronal activation during and after acute psychosis
por: Sheridan Rains, Luke, et al.
Publicado: (2012)

Do Hummingbirds See in Ultraviolet?
por: Curé, M, et al.
Publicado: (2009)

Musicians: Larks, Owls or Hummingbirds?
por: Gjermunds, Nikita, et al.
Publicado: (2019)

Outperforming hummingbirds’ load-lifting capability with a lightweight hummingbird-like flapping-wing mechanism
por: Leys, Frederik, et al.
Publicado: (2016)

CT abnormalities in late-onset schizophrenia and schizoaffective disorder correlate with number of psychotic episodes and cognitive dysfunction
por: Savina, M., et al.
Publicado: (2021)

Effects of psychosis-associated genetic markers on brain volumetry: a systematic review of replicated findings and an independent validation
por: Vouga Ribeiro, Nuno, et al.
Publicado: (2022)

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017)

The Psychological Impact of COVID-19 Pandemic on Suicidal Thoughts in the United Kingdom
por: Rathod, Shanaya, et al.
Publicado: (2022)

Fundamental Role of Methylenetetrahydrofolate Reductase 677 C → T Genotype and Flavin Compounds in Biochemical Phenotypes for Schizophrenia and Schizoaffective Psychosis
por: Fryar-Williams, Stephanie
Publicado: (2016)

SCHIZOAFFECTIVE DISORDER : CONSISTENCY OF DIAGNOSIS
por: Shrivastava, Amresh, et al.
Publicado: (1999)

Schizoaffective Disorder and Concurrent Rhabdomyolysis
por: Varkey, Thomas, et al.
Publicado: (2021)

To live with a Schizoaffective disorder
por: Arndtzén, Mats, et al.
Publicado: (2020)

19.4 CAT IN FIRST-EPISODE PSYCHOSIS: FEASIBILITY, ACCEPTABILITY AND POTENTIAL TO ENHANCE VOCATIONAL RECOVERY
por: Allott, Kelly
Publicado: (2018)

Collaborative, individualised lifestyle interventions are acceptable to people with first episode psychosis; a qualitative study
por: Pedley, Rebecca, et al.
Publicado: (2018)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

An RFID Based Smart Feeder for Hummingbirds
por: Ibarra, Vicente, et al.
Publicado: (2015)

Hummingbird sign in progressive supranuclear palsy
por: Verma, Rajesh, et al.
Publicado: (2012)

Sugar Metabolism in Hummingbirds and Nectar Bats
por: Suarez, Raul K., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_853aa6t89lnldvcjpmpnthv8dd